JMAC Enterprises’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-5,071
Closed -$305K – 118
2025
Q1
$305K Sell
5,071
-25
-0.5% -$1.55K 0.07% 103
2024
Q4
$297K Hold
5,096
– – 0.05% 150
2024
Q3
$302K Sell
5,096
-710
-12% -$40.5K 0.05% 156
2024
Q2
$325K Sell
5,806
-81,589
-93% -$4.57M 0.06% 145
2024
Q1
$5.12M Buy
87,395
+10,545
+14% +$596K 0.95% 29
2023
Q4
$4.15M Buy
76,850
+9,089
+13% +$444K 0.89% 28
2023
Q3
$3.29M Buy
67,761
+4,610
+7% +$245K 0.81% 31
2023
Q2
$3.57M Buy
63,151
+1,436
+2% +$79.1K 0.88% 29
2023
Q1
$3.33M Buy
61,715
+477
+0.8% +$25.4K 0.85% 30
2022
Q4
$3.22M Sell
61,238
-2,329
-4% -$118K 0.89% 28
2022
Q3
$3M Buy
63,567
+1,404
+2% +$72.8K 0.84% 30
2022
Q2
$3.14M Buy
62,163
+2,495
+4% +$136K 0.81% 29
2022
Q1
$3.64M Sell
59,668
-181
-0.3% -$10.8K 0.86% 29
2021
Q4
$3.6M Buy
+59,849
New +$3.83M 0.85% 30

Other funds holding IHI

JMAC Enterprises's IHI Position: Q2 2025 in Review

JMAC Enterprises sold out of iShares US Medical Devices ETF (IHI) in Q2 2025, closing a stake of 5,071 shares — an estimated $305K sold.

JMAC Enterprises first reported a position in IHI in Q4 2021 and held it in 14 quarters. The position peaked at $5.12M in Q1 2024. 549 funds tracked by Wall St. Rank hold IHI as of Q2 2025.

  • JMAC Enterprises reported no remaining iShares US Medical Devices ETF position as of Q2 2025 after selling out during the quarter.
  • JMAC Enterprises sold 5,071 iShares US Medical Devices ETF shares in Q2 2025, an estimated $305K.
  • JMAC Enterprises first reported a position in iShares US Medical Devices ETF in Q4 2021 and held it in 14 quarters.
  • JMAC Enterprises's iShares US Medical Devices ETF position peaked at $5.12M in Q1 2024.
  • 549 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2025.

Based on JMAC Enterprises's 13F filing for Q2 2025, filed 21 Jul 2025.